Team:MIT

From 2014.igem.org

(Difference between revisions)
Line 29: Line 29:
</tr>
</tr>
<tr>
<tr>
-
<td width=33.3%>[LilRB2/PirB]<br>Natural AB receptor</td>
+
<td width=33.3%><img src="https://static.igem.org/mediawiki/2014/e/e9/MIT_Native_receptor_homepage.png"><br>Natural AB receptor</td>
<td width=33.3%>[BCR]<br>Engineered AB receptor</td>
<td width=33.3%>[BCR]<br>Engineered AB receptor</td>
<td width=33.3%>[miRNA]<br>Sensors for Alzheimer’s state</td>
<td width=33.3%>[miRNA]<br>Sensors for Alzheimer’s state</td>

Revision as of 03:51, 15 October 2014

 


Image Map
Home Our Project Lab Work Outreach About Us Medals


[Dying Neuron]
Neurodegenerative Disease		 [6th]
Leading cause of death in the US		 [Vaccine]
Current diagnosis and therapeutics are not effective
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by memory loss, behavioral problems… There is currently no cure for this disease, and existing diagnosis methods leave much to be desired. MIT iGEM 2014 has set out to change this. By detecting molecular biomarkers for AD, such as miRNAs and neurotoxic beta-amyloid plaques, and by regulating the production of beta-amyloid plaques, MIT iGEM hopes to create a dynamic solution for patients with Alzheimer’s disease. Looking ahead, … delivery.
DETECT → TREAT → DELIVER
Detection

Natural AB receptor		 [BCR]
Engineered AB receptor		 [miRNA]
Sensors for Alzheimer’s state
TREATMENT
[APP]
Regulate AB production
and degredation
Future
[Virus]
Ways to deliver our circuit		 [Survey]
Public Opinion Survey

Retrieved from "http://2014.igem.org/Team:MIT"